Cempra to Present at the Jefferies 2015 Global Healthcare Conference
26 mai 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., May 26, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Presenting Additional Data From the Phase 3 Oral Solithromycin Study in Community Acquired Bacterial Pneumonia at the American Thoracic Society Conference
19 mai 2015 07h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., May 19, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present Solithromycin Data at Two Upcoming Medical Conferences
12 mai 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., May 12, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports First Quarter 2015 Financial Results and Provides Corporate Update
30 avr. 2015 16h04 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., April 30, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report First Quarter 2015 Financial Results
23 avr. 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., April 23, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at Two Upcoming Scientific Conferences
17 avr. 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., April 17, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Participate in Jefferies 2015 Antibiotic Summit Investor Conference
16 mars 2015 17h21 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., March 16, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
25 févr. 2015 16h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report Fourth Quarter and Full Year 2014 Financial Results
17 févr. 2015 08h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at Three Upcoming Investor Conferences
03 févr. 2015 08h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...